TherapeuticsMD Inc
Change company Symbol lookup
Select an option...
TXMD TherapeuticsMD Inc
NVEC NVE Corp
GHRS GH Research PLC
NWFL Norwood Financial Corp
APN Apeiron Capital Investment Corp
TSLA Tesla Inc
TOL Toll Brothers Inc
LHAA Lerer Hippeau Acquisition Corp
PSUD Petrosun Inc
ADIL Adial Pharmaceuticals Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products from pregnancy prevention through menopause. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

Closing Price
$6.22
Day's Change
-0.13 (-2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.41
Day's Low
6.11
Volume
(Average)
Volume:
88,619

10-day average volume:
96,558
88,619

Company Profile

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products from pregnancy prevention through menopause. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
0.64x
Price/Book (MRQ)
--
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

August 2022
Current Month
413.8K
Previous Month
620.7K
Percent of Float
4.96%
Days to Cover
2.7113 Days

Share Information

TXMD is in a share class of common stock
Float
8.4M
Shares Outstanding
9.4M
Institutions Holding Shares
71
39.89%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Thomas G. ThompsonChmn.
  • Brian A. BernickCo-CEO
  • Mark A. GlickmanCo-CEO
  • Michael DoneganCFO
  • Marlan D. WalkerCounsel

Address

Insider Trading

During the most recent quarter, 648K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.